Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Teleflex Incorporated
Deal Watch: Moderna, ElevateBio Subsidiary To Combine mRNA With Gene Editing
Moderna and Life Edit will team up to develop transformative or curative therapies for challenging genetic diseases. Erytech and Pherecydes unveil plan to merge and extend runway into 2024.
Dealmaking Quarterly Statistics, Q3 2022
During Q3, biopharma merger and acquisition value reached $15.4bn and drew in $37.6bn in potential deal value from alliances. Device company M&A values reached $550m, while in vitro diagnostic firms and research tools players completed M&A activity that totaled $1.9bn.
FDA Announces Class I Recall On Arrow International Cardiac Catheter Device
The US FDA has announced a high-risk class I recall on a cardiac catheter from Teleflex Inc. subsidiary Arrow International due to the risk of tip damage during use.
Glaukos Takes Another Hit From CMS; Investors Respond Negatively As Stock Falls
The US Medicare agency's new rule for facility fees brings more bad news for Glaukos; Wells Fargo downgrades company’s stock in response.
- Medical Devices
- Implantable Devices
- Infusion Therapy Equipment and Supplies
- Surgical Equipment & Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Other Names / Subsidiaries
- Arrow International
- Eon Surgical Ltd
- Hotspur Technologies
- Essential Medical, Inc.
- Hudson Respiratory Care, Inc.
- LMA International N.V.
- NeoTract, Inc.
- Nostix, LLC
- Pyng Medical Corporation
- Semprus BioSciences
- Standard Bariatrics, Inc.
- Ultimate Medical
- Vascular Solutions
- Vasonova Inc.
- Vidacare Corporation
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.